Gentris is Practice Management (Healthcare) in United States that focus on research organizations business. Founded in 2001. They cover business area such as apply clinical pharmacogenomic, pharmaceutical and biotech company, clinical research organization, PGx testing service, development, validation, clinical sample logistic, seamless integration, genomic biomarker service, polymorphism, drug response, adverse drug event.
Practice Management (Healthcare)
2001
( 23 years old in 2024 )
Research Organizations
-
133 Southcenter Court
Suite 400
Morrisville, NC 27560
United States
Private
apply clinical pharmacogenomicpharmaceutical and biotech companyclinical research organizationPGx testing servicedevelopmentvalidationclinical sample logisticseamless integrationgenomic biomarker servicepolymorphismdrug responseadverse drug event
* We use standard office opening hours in near Gentris's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Gentris is Practice Management (Healthcare) business from United States that founded in 2001 (23 years old in 2024), Gentris business is focusing on Research Organizations.
Gentris headquarter office and corporate office address is located in 133 Southcenter Court Suite 400 Morrisville, NC 27560 United States.
Gentris was founded in United States.
In 2024, Gentris is currently focus on research organizations sector.
Above is snippet of Google Trends for "research organizations" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Gentris, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
